India Morning Newsletter, March 13-January 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

India Morning Newsletter, March 13

Mar 12, 2024 8:31 PM

To access a PDF version of this newsletter, please click here

If you would like to receive this newsletter via email, please register at:

https://solutions.refinitiv.com/MNCIndiaSubscriptionpage

For an index of our newsletters click on

Previous page： What's Going On With Theriva Biologics Stock? Next page： Why BioCardia (BCDA) Stock Is Falling Today

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

What's Going On With Theriva Biologics Stock?

Sep 1, 2024

Theriva Biologics, Inc. ( TOVX ) shares are trading higher Friday on continued momentum following a series of catalysts this week. Here's a look at the details. The Details: Theriva Biologics ( TOVX ) announced on Monday that it was granted Rare Pediatric Drug Designation (RPDD) by the U.S. Food and Drug Administration (FDA) for VCN-01 for the treatment of...

Why BioCardia (BCDA) Stock Is Falling Today

Sep 1, 2024

BioCardia Inc ( BCDA ) shares are trading lower by 12% to $3.53 during Friday’s session after the company announced the pricing of an upsized public offering, involving 2.4 million shares of common stock (or pre-funded warrants) and accompanying warrants to purchase an additional 2.4 million shares. What Else: Each share and warrant is priced at $3.00, with expected gross...

--Street Color: Equinor Plans to Downsize Renewables Unit, Bloomberg Says

Sep 1, 2024

12:34 PM EDT, 08/30/2024 (MT Newswires) -- Price: 26.73, Change: -0.45, Percent Change: -1.67 ...

Atlassian Insider Sold Shares Worth $1,309,885, According to a Recent SEC Filing

Sep 1, 2024

03:27 AM EDT, 08/29/2024 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Co-Chief Executive Officer, Co-Founder, on August 27, 2024, sold 7,948 shares in Atlassian ( TEAM ) for $1,309,885. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 182,804 shares of the company, with 182,804 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024006543/xslF345X05/primarydocument.xml Price: 161.74, Change:...